Company & Sponsor Intelligence

West Virginia University

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials8

Recruiting2

Completed4

Countries1

Therapeutic footprint

adhdother_psychiatrypain_neuropathysubstance_use

Indexed studies

NCT04415970Understanding Physiology During Float-REST and the Consequential Effects on Subjective and Objective Recovery
other_psychiatry · United StatesNA

NCT06350175Emergency Department Management of Tobacco Use Disorder
other_psychiatry · PHASE4

NCT05976672Machine Learning Technology in Predicting Relapse and Implementing Peer Recovery Intervention Before Drug Use Occurs
substance_use · United StatesNA

NCT06808503NIMH Clinical Pathway in Rural Appalachian School-based Health Clinics
other_psychiatry · United StatesNA

NCT05963555PBM or Dry Float Therapy on Sleep Quality in Middle-aged and Elderly
other_psychiatry · United StatesNA

NCT05260918Examining the Effects of Float-REST for Recovery in Individuals With Chronic Lower Back Pain
pain_neuropathy · United StatesNA

NCT05353244Effects of PrTMS on Performance
other_psychiatry · United StatesNA

NCT02543359A Statewide Trial to Compare Three Training Models for Implementing an Evidence-based Treatment (EBT)
adhd · United StatesNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →